Literature DB >> 10722961

Epilepsy in adolescents and young adults with autistic disorder.

P Giovanardi Rossi1, A Posar, A Parmeggiani.   

Abstract

Since the first description by Kanner (1943) the association between autistic disorder (AD) and epilepsy has been observed in 4-42% of patients. Some authors reported that seizures prevailed in adolescence but a systematic investigation has never been undertaken. We examined retrospectively 60 patients divided into two groups (with and without epilepsy and EEG paroxysmal abnormalities) with AD unrelated to a congenital or acquired encephalopathy (mean age 17 years 2 months). The aim was to investigate epilepsy, EEG paroxysmal abnormalities and possible etiological factors. The prevalence of epilepsy was 38.3%, much higher than that in a normal population of a similar age (6.6 per thousand). The prevalence of EEG paroxysmal abnormalities without epilepsy was 6.7%, higher than that in a population of adolescents and adults with psychiatric pathologies (2. 6%). Seizure onset was after age 12 years in 66.7% of cases. The most common type of epilepsy was partial in 65.2% and four patients (17.4%) had a benign childhood epilepsy with centro-temporal spikes. At the last observation 44.4% of patients had been seizure-free for 2 years or more. There were no organic factors influencing the development of epilepsy but familial and personal antecedents, mental retardation and CT scan/MRI data may suggest an early brain dysfunction responsible for AD and epilepsy.

Entities:  

Mesh:

Year:  2000        PMID: 10722961     DOI: 10.1016/s0387-7604(99)00124-2

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  29 in total

Review 1.  Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.

Authors:  Stephen R Dager; Neva M Corrigan; Todd L Richards; Stefan Posse
Journal:  Top Magn Reson Imaging       Date:  2008-04

Review 2.  Childhood epilepsy and autism spectrum disorders: psychiatric problems, phenotypic expression, and anticonvulsants.

Authors:  Sally J Robinson
Journal:  Neuropsychol Rev       Date:  2012-08-09       Impact factor: 7.444

3.  Exome sequencing identifies de novo gain of function missense mutation in KCND2 in identical twins with autism and seizures that slows potassium channel inactivation.

Authors:  Hane Lee; Meng-chin A Lin; Harley I Kornblum; Diane M Papazian; Stanley F Nelson
Journal:  Hum Mol Genet       Date:  2014-02-05       Impact factor: 6.150

4.  The training of New Jersey emergency service first responders in autism awareness.

Authors:  Edward Kelly; Connie Hassett-Walker
Journal:  Police Pract Res       Date:  2016-01-04

Review 5.  Epilepsy in autism spectrum disorders.

Authors:  Roberto Canitano
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-24       Impact factor: 4.785

6.  Exploring the relationship between autism spectrum disorder and epilepsy using latent class cluster analysis.

Authors:  Michael L Cuccaro; Roberto F Tuchman; Kara L Hamilton; Harry H Wright; Ruth K Abramson; Jonathan L Haines; John R Gilbert; Margaret Pericak-Vance
Journal:  J Autism Dev Disord       Date:  2012-08

7.  Soy-based diet exacerbates seizures in mouse models of neurological disease.

Authors:  Cara J Westmark; Pamela R Westmark; James S Malter
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Epilepsy among children and adolescents with autism spectrum disorders: a population-based study.

Authors:  Elina Jokiranta; Andre Sourander; Auli Suominen; Laura Timonen-Soivio; Alan S Brown; Matti Sillanpää
Journal:  J Autism Dev Disord       Date:  2014-10

Review 9.  The role of epilepsy and epileptiform EEGs in autism spectrum disorders.

Authors:  Sarah J Spence; Mark T Schneider
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

10.  Incidence and behavioral correlates of epileptiform abnormalities in autism spectrum disorders.

Authors:  Caitlin K Mulligan; Doris A Trauner
Journal:  J Autism Dev Disord       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.